Knee implants price cap extended by NPPA, ensuring continued affordability for patients in need of essential medical procedures.
Category: pharma
Lower Cancer Drug Prices: Worst Impact on Patients Yet
Lower cancer drug prices have yet to benefit patients in the city.
FDA Accelerated Approval: Is Rybrevant Faspro the Best Option?
FDA Accelerated Approval has been granted to Rybrevant Faspro, a significant development in cancer treatment.
Pharmaceutical prices Kazakhstan drop: Proven benefits for consumers
Pharmaceutical prices Kazakhstan have dropped significantly, providing clear benefits for consumers across the nation.
FDA Approval for VOCERYQ: Proven Treatment for Adult RRP
FDA approval for VOCERYQ marks a significant milestone in adult RRP treatment.
Aurobindo Perampanel Approval: Worth $67 Million Impact
Aurobindo Perampanel approval could significantly impact the stock market, with a $67 million valuation at stake.
Severe Hypertriglyceridemia Market: Is It the Best Growth Opportunity?
Severe Hypertriglyceridemia Market is poised for growth with new therapies. Discover the potential impact of Ionis’ TRYNGOLZA and more.
Trade Margins on Anti-Cancer Drugs: Clear Price Drop Ahead
Trade margins on anti-cancer drugs are capped at 30%, leading to potential price drops of up to 70%.
Drug Price Controls: The Right Way to Lower Costs
Drug price controls are essential for making medications affordable for all.
Cancer medicine price controls: Smart Proven Savings Ahead
Cancer medicine price controls are set to save patients ₹2,500 crore annually as drug prices may fall up to 70%.
